According to a new scientific study published in the journal Nature Metabolism, non-caloric sweeteners (often found in diet ...

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Researchers at the National Institutes of Health (NIH) have identified a series of changes in the architecture and cell ...

Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...

Discover the 5 most common dog health issues, including obesity, dental disease, and parasites, and learn practical tips to ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Anti-obesity drug popularity presents opportunities for science innovation. Strategies to increase protein and fiber can help prevent side effects.